Lv7
4980 积分 2021-01-10 加入
ADAM Metalloproteinases as Potential Drug Targets
4天前
已完结
Molecular glue degraders of HuR suppress BRAF-mutant colorectal cancer
5天前
已完结
Brepocitinib, Zimlovisertib, and Ropsacitinib in Hidradenitis Suppurativa
6天前
已完结
Efficacy and Safety of Zimlovisertib, Ritlecitinib, and Tofacitinib, Alone and in Combination, in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate
6天前
已完结
Phase II study of E7070 in patients with metastatic melanoma
8天前
已完结
Recent advances in anticancer mechanisms of molecular glue degraders: focus on RBM39-dgrading synthetic sulfonamide such as indisulam, E7820, tasisulam, and chloroquinoxaline sulfonamide
8天前
已完结
Optimization of Potent Ligands for the E3 Ligase DCAF15 and Evaluation of Their Use in Heterobifunctional Degraders
8天前
已完结
Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin Lymphoma
12天前
已完结
Mining the CRBN Target Space Redefines Rules for Molecular Glue-induced Neosubstrate Recognition
13天前
已完结
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials
13天前
已完结
皖公网安备34019202002308
